Importance of serum source for the in vitro replicative senescence of human bone marrow derived mesenchymal stem cells

Journal of Cellular Physiology

Volumn 226, Issue 11, 2011, Pages 2908-2915

  Duggal, Shivali ^a   Brinchmann, Jan E ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CULTURE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL POPULATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TELOMERE; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CATTLE; CELL AGING; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; FETAL BLOOD; HEAT-SHOCK PROTEINS; HUMANS; MESENCHYMAL STEM CELLS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; UP-REGULATION;

BOVINAE;

EID: 80051916551     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22637     Document Type: Article

References (38)

1. Arrigo AP. 2007. The cellular "networking" of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv Exp Med Biol 594: 14-26.
2. Arrigo AP, Virot S, Chaufour S, Firdaus W, Kretz-Remy C, Az-Latoud C. 2005. Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. Antioxid Redox Signal 7: 414-422.
3. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. 2000. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 28: 707-715.
4. Berger MG, Veyrat-Masson R, Rapatel C, Descamps S, Chassagne J, Boiret-Dupre N. 2006. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24: 2888-2890.
5. Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, Kluter H. 2009. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
6. Caplan AI, Bruder SP. 2001. Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol Med 7: 259-264.
7. Chen JH, Stoeber K, Kingsbury S, Ozanne SE, Williams GH, Hales CN. 2004. Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J Biol Chem 279: 49439-49446.
8. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. 2005. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764.
9. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B. 2009. Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci 1176: 118-123.
10. Dahl JA, Duggal S, Coulston N, Millar D, Melki J, Shahdadfar A, Brinchmann JE, Collas P. 2008. Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 52: 1033-1042.
11. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
12. Hayflick L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636.
13. Heiskanen A, Satomaa T, Tiitinen S, Laitinen A, Mannelin S, Impola U, Mikkola M, Olsson C, Miller-Podraza H, Blomqvist M, Olonen A, Salo H, Lehenkari P, Tuuri T, Otonkoski T, Natunen J, Saarinen J, Laine J. 2007. N-Glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25: 197-202.
14. Honn KV, Singley JA, Chavin W. 1975. Fetal bovine serum: A multivariate standard. Proc Soc Exp Biol Med 149: 344-347.
15. Kocaoemer A, Kern S, Kluter H, Bieback K. 2007. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25: 1270-1278.
16. Le BK. 2003. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5: 485-489.
17. Lund TC, Glass TJ, Tolar J, Blazar BR. 2009. Expression of telomerase and telomere length are unaffected by either age or limb regeneration in Danio rerio. PLoS ONE 4: e7688.
18. Mannello F, Tonti GA. 2007. Concise review: No breakthroughs for human mesenchymal and embryonic stem cell culture: Conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold. Stem Cells 25: 1603-1609.
19. Mayack SR, Shadrach JL, Kim FS, Wagers AJ. 2010. Systemic signals regulate ageing and rejuvenation of blood stem cell niches. Nature 463: 495-500.
20. Muller M. 2009. Cellular senescence: Molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal 11: 59-98.
21. Noer A, Boquest AC, Collas P. 2007. Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol 8: 18.
22. Phinney DG, Prockop DJ. 2007. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-Current views. Stem Cells 25: 2896-2902.
23. Piotrowicz RS, Weber LA, Hickey E, Levin EG. 1995. Accelerated growth and senescence of arterial endothelial cells expressing the small molecular weight heat-shock protein HSP27. FASEB J 9: 1079-1084.
24. Sacchetti B, Funari A, Michienzi S, Di CS, Piersanti S, Saggio I, Tagliafico E, Ferrari S, Robey PG, Riminucci M, Bianco P. 2007. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336.
25. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D. 2007. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
26. Sethe S, Scutt A, Stolzing A. 2006. Aging of mesenchymal stem cells. Ageing Res Rev 5: 91-116.
27. Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE. 2005. In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23: 1357-1366.
28. Sharpless NE, Depinho RA. 2004. Telomeres, stem cells, senescence, and cancer. J Clin Invest 113: 160-168.
29. Sharpless NE, Depinho RA. 2007. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8: 703-713.
30. Sharpless NE, Schatten G. 2009. Stem cell aging. J Gerontol A Biol Sci Med Sci 64: 202-204.
31. Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M, Kohno Y, Ito K, Fujibayashi S, Neo M, Nakayama T, Nakamura T, Toguchida J. 2007. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25: 2371-2382.
32. Soti C, Csermely P. 2002. Chaperones come of age. Cell Stress Chaperones 7: 186-190.
33. Stolzing A, Jones E, McGonagle D, Scutt A. 2008. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 129: 163-173.
34. Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. 2004. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32: 1212-1225.
35. Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le BK. 2007. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92: 1208-1215.
36. Takagi M, Nakamura T, Matsuda C, Hattori T, Wakitani S, Yoshida T. 2003. In vitro proliferation of human bone marrow mesenchymal stem cells employing donor serum and basic fibroblast growth factor. Cytotechnology 43: 89-96.
37. Van ZG, Liang Y. 2003. The role of stem cells in aging. Exp Hematol 31: 659-672.
38. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD. 2008. Replicative senescence of mesenchymal stem cells: A continuous and organized process. PLoS ONE 3: e2213.